Professor Jim Smith, now Professor of Pharmacy Practice and Policy at the University of Sunderland, will also highlight several other controversial issues that surround the pharmaceutical sector and its practice.
Prof Smith was appointed England’s Chief Pharmaceutical Officer in 2001 and was in charge of implementing the Government's "Vision for Pharmacy" programme.
In his inaugural lecture at the university on Thursday, Prof Smith will explain why millions are being wasted on prescribed drugs that people are not using.
He will argue that of the £11bn spent each year on prescription drugs a substantial proportion of that is wasted through non-compliance, often impairing the health of those people for who the drugs are meant.
Prof Smith says: “There is good evidence that people accumulate large quantities of drugs but don’t use them, wasting money that the NHS can ill afford.
“There is also evidence that non-compliance it is linked to socio economic status – which has connotations for places like Sunderland – widening the health gap.
“Every Primary Care Trust is struggling with the costs of providing health care. However, so many of these medicines are not being taken, which is leading to further health problems
“There is evidence for example that some heart attack victims, who may be prescribed up to four drugs, do not take them properly and puts them at greater risk of a second heart attack.
“It’s a major problem. Fifteen per cent of NHS spending is on prescribed drugs.
“Many people, ultimately almost all of us, rely on medicines for their wellbeing. They can be life-enhancing and, for many people, lifesaving.
“Modern medicines are the product of an unprecedented scientific, clinical and industrial enterprise in which Britain is a world leader. They are contributing significantly to the increases in life expectancy and quality of life now being seen in this country. But our attitudes to medicines are ambivalent.
“We distrust the corporations that have, so successfully, developed new medicines. Governments laud the economic success of the industry but are sometimes reluctant to meet the cost of new drugs.
“The public, influenced at times by the news media, call for government bans in response to ‘drug scares’ but, paradoxically, also press for new drugs to be introduced across the NHS before clinical and economic evaluations are complete.”
Prof Smith’s lecture will explore these issues and argue for a mature and informed approach to the medicines we take.
He has worked as a community, industrial and hospital pharmacist and has held senior posts in health authorities in the North of England and in Central Government.
He has held consultancies with a number of pharmaceutical companies and with the World Health Organisation. In 2006 he was admitted as a fellow of the Faculty of Public Health of the Royal Colleges of Physicians of the United Kingdom.
Tony Kerr | alfa
Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View
22.06.2018 | University of Sussex
New cellular pathway helps explain how inflammation leads to artery disease
22.06.2018 | Cedars-Sinai Medical Center
In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.
Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...
Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...
Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.
Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...
The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.
Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.
An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.
Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...
13.06.2018 | Event News
08.06.2018 | Event News
05.06.2018 | Event News
22.06.2018 | Materials Sciences
22.06.2018 | Earth Sciences
22.06.2018 | Life Sciences